Massachusetts General Hospital

The Diabetes Clinical Research Center and its staff have played a leadership role in the conduct of several of the most important clinical trials in diabetes of the past two decades.

The major accomplishments of the Diabetes Center have been the following:

• establishment of hemoglobin A1c as a seminal research and clinical assay
• development of intensive treatment regimens for Type 1 diabetes
• introduction of GLP 1, 7-37 as a potential new therapy for Type 2 diabetes
• delineation of the relationship between subdiabetic levels of hyperglycemia and cardiovascular disease
• conduct and completion of the Epidemiology of Diabetes Interventions and Complication study (EDIC) and Diabetes Prevention Program Outcomes Study (DPP) studies, which established the means to prevent complications of diabetes and to prevent Type 2 diabetes, respectively.

The EDIC and DPP have been hailed as the most important studies in diabetes since the discovery of insulin.

David Nathan, MD

Enrico Cagliero, MD

Linda Delahanty, MS, RD

Richard Grant, MD, MPH

Mary E. Larkin, RN

Lynne Levitsky, MD
Director of Pediatric Endocrinology

Mara Lorenzi, MD

Charles McKitrick, RN

James Meigs, MD, MPH

Director Diabetes Center

Richard Pompei, RN

Christine Stevens, RN

Robert Sutherlin, RN

Ravi Thadhani, MD

MHS Kids for a Cure Benefit Dinner

Come to the Kids for a Cure benefit dinner at Palmer's Crossing Restaurant in Larchmont, NY on June 24, 2013. Proceeds benefit diabetes research at the Faustman Laboratory at Mass General.